McKesson recently announced that it has acquired HealthQX, bolstering its portfolio by adding the value-based payment technology, ClarityQX. Read More »

Health Smiles van out of commission; needed to help Central Valley children receive dental care. Read More »

The American Pharmacists Association Academy of Student Pharmacists (APhA-ASP) will be hosting a program focused on leadership and professional development in collaboration with Amgen, Cardinal Health and Rite Aid on the weekend of July 15-17.  Read More »

White House Drug Control Policy Director to lead town hall discussion at the American Osteopathic Association's annual meeting. Read More »

Aetna Better Health of Virginia recently donated $100,000 in community grants to five non-profit organizations in Virginia that are committed to helping improve health care and the quality of life for the people of Virginia. Read More »

Pharmacy chain throws itself into relief efforts after massive flash floods on June 23. Read More »

Bexion Pharmaceuticals, LLC today announced that its application to begin a First-in-Human Phase 1 clinical trial with BXQ-350 has been accepted by the U..S Food and Drug Administration (FDA).  Read More »

Pfizer announces positive results from year-long S-TRAC trial of SUTENT. Read More »

Virginia Cancer Specialists (VCA) has enrolled its first patient in its upcoming advanced lung cancer clinical trial, making it the first center in the world to do so. Read More »

TPP program rigorously evaluated teen prevention programs for effectiveness. Read More »

The fifth edition of the leading pharmaceutical compounding textbook was released last week. Read More »

An advisory panel of the Federal Drug Administration (FDA) recently recommended approval of a medication manufactured by Amgen as a feasible alternative product to Humira, a brand created by AbbVie. Read More »

FDA approves Differin Gel as an over-the-counter medication; prescription no longer needed. Read More »

The National Association of Chain Drug Stores (NACDS) recently announced a nationwide tour to promote the Test2Learn Community-Based Pharmacogenomics Certificate Program this fall with its partner, the University of Pittsburgh School of Pharmacy. Read More »

The World Health Organization (WHO) this week prequalified the four-dose, multi-dose vial (MDV) for Pfizer Inc.’s Prevenar 13. Read More »

Namzaric approved as a combination therapy for moderate to severe Alzheimer's patients. Read More »

Extended-release Belviq XR tablets approved for use with low-calorie diet and exercise plan. Read More »

Allergan recently announced that it has surpassed its goal of donating $1 million worth of REFRESH eye drops to first responders around the country.  Read More »

Encouraging test results in bioavailability of therapeutically equivalent dose used for COPD treatment. Read More »

Lannett Company, Inc. recently announced that an Acceptable for Filing letter has been issued to its strategic partner Sparsha Pharma USA, Inc. from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fentanyl Transdermal System. Read More »